Rosenberger, Andrea Morrema, Tjado Gerritsen, Wouter van Haastert, Elise Snkhchyan, Hripsime Hilhorst, Riet Rozemuller, Annemieke Scheltens, Philip van der Vies, Saskia Hoozemans, Jeroen Additional file 3: Figure S2. of Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer’s disease pathology Expression of CK2 in the hippocampus and temporal cortex. Protein expression of CK2 was assessed by Western blot analysis using mouse anti-CK2 which detects both CK2α and CK2α’ (see Additional file 2: Figure S1). a Western blot analysis of brain extracts from the hippocampus. b Western blot analysis of brain extracts from the temporal cortex. AD and non-demented control (CON) cases analysed by Western blotting are listed in (Table 1). Braak stages are indicated, and recombinant CK2α and CK2α’ were used as positive controls. (PDF 137 kb) Alzheimer’s disease;Casein kinase 2;Protein kinase CK2;Neuroinflammation;Astrocytes 2016-01-06
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_Figure_S2_of_Increased_occurrence_of_protein_kinase_CK2_in_astrocytes_in_Alzheimer_s_disease_pathology/4389527
10.6084/m9.figshare.c.3619577_D3.v1